ResMed Inc.
US ˙ NYSE ˙ US7611521078

SecurityRMD / ResMed Inc.
InstitutionJJJ Advisors Inc.
Latest Disclosed Ownership447 shares
Latest Disclosed Value $ 85,565
JJJ Advisors Inc. reports 8.59% decrease in ownership of RMD / ResMed Inc.

On July 25, 2024 - JJJ Advisors Inc. filed a 13F-HR form disclosing ownership of 447 shares of ResMed Inc. (US:RMD) valued at $85,565 USD as of June 30, 2024. The entity filed a previous 13F-HR on April 15, 2024 disclosing 489 shares of ResMed Inc.. This represents a change in shares of -8.59% during the quarter. The current value of the position is $87,630 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-07-25 2024-06-30 13F RESMED COM 761152107 447 -42 -8.59 86 -11.46 0.0179
2024-04-15 2024-03-31 13F RESMED COM 761152107 489 -1 -0.20 97 14.29 0.0206
2024-01-29 2023-12-31 13F RESMED COM 761152107 490 404 469.77 84 600.00 0.0204
2023-10-13 2023-09-30 13F RESMED COM 761152107 86 -343 -79.95 13 -87.10 0.0034
2023-07-11 2023-06-30 13F RESMED COM 761152107 429 -6 -1.38 94 -4.12 0.0258
2023-04-21 2023-03-31 13F RESMED COM 761152107 435 -50 -10.31 98 -5.83 0.0277
2023-01-23 2022-12-31 13F RESMED COM 761152107 485 -53 -9.85 104 -12.71 0.0292
2022-10-17 2022-09-30 13F RESMED COM 761152107 538 -9 -1.65 118 -10.61 0.0384
2022-08-03 2022-06-30 13F RESMED COM 761152107 547 239 77.60 132 76.00 0.0392
2022-05-05 2022-03-31 13F RESMED COM 761152107 308 79 34.50 75 25.00 0.0207
2022-02-02 2021-12-31 13F RESMED COM 761152107 229 35 18.04 60 17.65 0.0179
2021-10-25 2021-09-30 13F/A-1 RESMED COM 761152107 194 48 32.88 51 41.67 0.0180
2021-10-19 2021-09-30 13F RESMED COM 761152107 194 48 51 0.0179
2021-07-28 2021-06-30 13F RESMED COM 761152107 146 -28 -16.09 36 5.88 0.0131
2021-04-28 2021-03-31 13F RESMED COM 761152107 174 -8 -4.40 34 -12.82 0.0136
2021-01-26 2020-12-31 13F RESMED COM 761152107 182 148 435.29 39 550.00 0.0189
2020-10-19 2020-09-30 13F RESMED COM 761152107 34 34 6 0.0032
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.